[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
From the Food and Drug Administration
October 4, 2000

New Hearing Implant Approved

Author Affiliations

Not Available

Not Available

JAMA. 2000;284(13):1640. doi:10.1001/jama.284.13.1640-JFD00008-3-1

The FDA has approved a new type of surgically implantable middle ear hearing device (Vibrant Soundbridge, Symphonix Inc, San Jose, Calif) designed to improve sound perception by adults with moderate-to-severe sensorineural hearing loss. The device is an alternative to traditional hearing aids.

The device consists of two main components: a vibrating ossicular prosthesis that is implanted under the skin behind the ear and surgically attached to the long process of the incus, and an external amplification system held by a magnet on top of the prosthesis. The external system picks up sound, converts it into an electric signal, and transmits it across the skin into a transducer in the prosthesis, causing it to vibrate. The vibration mechanically stimulates the auditory ossicles, which the patient perceives as sound.

First Page Preview View Large
First page PDF preview
First page PDF preview